Kalaris Therapeutics (KLRS) vs OKYO Pharma (OKYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OKYO Pharma (OKYO) has outperformed Kalaris Therapeutics (KLRS) over the past year, losing 30.5% versus a loss of 66.8%. OKYO Pharma is the larger company by market cap ($72.9 million vs $59.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KLRS | OKYO |
|---|---|---|
| Share price | $2.50 | $1.39 |
| Market cap | $59.51M | $72.95M |
| 1-day change | -2.34% | -2.73% |
| YTD return | -69.67% | -31.88% |
| 1-year return | -66.84% | -30.54% |
| 5-year return | -99.50% | — |
| EPS (TTM) | $-2.02 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.88 | $3.20 |
| 52-week low | $2.35 | $1.27 |
| Distance from 52-week high | -78.96% | -56.56% |
| Average volume | 251.42K | 94.59K |
| Shares outstanding | 23.80M | 52.48M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OKYO has outperformed KLRS by 36.3 percentage points over the past year.
KLRS vs OKYO FAQ
Which is bigger, Kalaris Therapeutics or OKYO Pharma?
OKYO Pharma (OKYO) is larger, with a market capitalization of $72.95M compared with $59.51M for Kalaris Therapeutics (KLRS).
Which stock has performed better over the past year, KLRS or OKYO?
OKYO returned -30.54% over the past 12 months, compared with -66.84% for KLRS (price return, excluding dividends). Past performance does not predict future results.
Are Kalaris Therapeutics and OKYO Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.